AstraZenca Pharma India Ltd.
Share Price Target & Analysis
NSE:ASTRAZEN
VWAP
Open
Close
High
Low
52 Week High
-69.00 (-1.02%)
ASTRAZEN
(PHARMA)Watch Carefully
52 Week Low
EPS
PE
PB
Economical
Quality
Diamond
Valuation
#Analysis
NSE: ASTRAZEN Share Price Financial Analysis & Valuation
AstraZenca Pharma India Ltd. (ASTRAZEN) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Mid Cap company with Market Capitalization of Rs 7044.8 (in Cr). Total number of free float shares are 2.5 (in Lacs).
AstraZenca Pharma India Ltd. is listed on NSE with Exchange ID - INE203A01020 and trading code is NSE:ASTRAZEN with short name AstraZeneca.
In the past 1 year, AstraZenca Pharma India Ltd. has declared an equity dividend of Rs 0.54 per share. At the current share price of ASTRAZEN at Rs 6695.50, this results in a dividend yield of 0.01 %.
As per the Fundamental Analysis of NSE:ASTRAZEN, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine ASTRAZEN underlying value and future prospects. All of this data is available in ASTRAZEN financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:ASTRAZEN, it is clearly understood that ASTRAZEN is Economical performer in terms of earnings and profit margins with an EPS of 86.44. NSE:ASTRAZEN book value per share as of today is 364.29. The current price to book ratio for ASTRAZEN as of Sep 15, 2026 is 18.38.
Valuation of the Stock: The current valuation of ASTRAZEN stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of ASTRAZEN whether to BUY this stock at current valuation. The delivery percentage of ASTRAZEN is 1662% is very crucial parameter which shows that 1662% investors are anticipating that the price of ASTRAZEN share should go up with VWAP at 6689.25.
Now, the main question is whether to BUY or SELL, NSE:ASTRAZEN at current valuation.
As per latest Analysis No. #1310:-
⇑ STRONG BUY ASTRAZEN if All Greens
⇗ BUY ASTRAZEN (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD ASTRAZEN (With Stop Loss) if only 1 Green
⇘ SELL ASTRAZEN if NO Green Indicator
NSE: ASTRAZEN Share Price Today (Sep 15, 2026)
(AstraZenca Pharma India Ltd. Daily Analysis on the basis of ASTRAZEN Intraday Graph & Trend)
AstraZenca Pharma India Ltd. share price moved Down by -1.02% from its previous close of Rs 6764.5. ASTRAZEN stock last traded price is 6695.50. ASTRAZEN share price trend is Down with a total of 14843 stocks traded till now. It has touched an intraday high of Rs 6778.5 and an intraday low of Rs 6600. The ASTRAZEN trading at 6695.50, Down by Rs. -69.00, or -1.02 percent which suggests that most of the Traders are anticipating that the price of ASTRAZEN share should go Down.
NSE: ASTRAZEN Share Price Tomorrow Prediction
(AstraZenca Pharma India Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of ASTRAZEN)
AstraZenca Pharma India Ltd. share price moved Down by -1.02%. ASTRAZEN share price short term trend is Down. It suggests that ASTRAZEN Share Price for Tomorrow remains the same with VWAP at 6689.25 will be treated as stop loss for intraday traders. AstraZenca Pharma India Ltd. Long term investors can follow the ASTRAZEN long term trend as mentiond in future forecast table.
NSE Code |
NSE: ASTRAZEN |
ASTRAZEN Share Price Today |
6695.50 |
ASTRAZEN Share Price Target Prediction for 2026 ^ |
6919.5 - 8727.2 |
ASTRAZEN Share Price Target Prediction for 2027*^ |
8727.2 - 10544.9 |
ASTRAZEN Share Price Target Prediction for 2028*^ |
10544.9 - 11283 |
ASTRAZEN Share Price Target Prediction for 2029*^ |
11847 |
ASTRAZEN Share Price Target Prediction for 2030*^ |
12186 |
ASTRAZEN Share Price Target Prediction for 2035*^ |
13282 |
| ASTRAZEN Current Book Value |
362.5 |
*AstraZenca Pharma India Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^ASTRAZEN share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
ASTRAZEN Technical Analysis
Candlestick Pattern: @6876.5| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 6897.5 | SELL | 6897.89 | SELL |
| MA_12 | 6999.81 | SELL | 7049.1 | SELL |
| MA_20 | 7212.57 | SELL | 7199.38 | SELL |
| MA_32 | 7579.53 | SELL | 7436.42 | SELL |
| MA_50 | 7758.86 | SELL | 7622.99 | SELL |
| MA_100 | 8078.12 | SELL | 7896.93 | SELL |
| MA_200 | 8386.52 | SELL | 8198.52 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 7212.57 | Downtrend |
| MACD | -6.16 | SELL |
| ADX | 46.27 | Strong Trend |
| DMI (+/-) | 9.14 / 31.42 | Downtrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 23.04 | Oversold |
| STOCHASTIC_K (Fast) | 26.21 | Neutral |
| STOCHASTIC_D (Slow) | 21.07 | Neutral |
| CCI | -77.04 | Neutral |
| PSAR | 7015.6 | SELL |
| TRUE RANGE | 142.5 | BUY |
| ATR | 161.3 | BUY |
| WILLIAMS R | -90.31 | Oversold |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 98.8 | Overbought |
| STOCHASTIC RSI D | 87.04 | Overbought |
| MOMENTUM | -1070 | SELL |
| Duration | Value |
|---|---|
| 1 Year | -24.54% |
| 3 Months | -18.65% |
| 1 Month | -13.47% |
| 1 Week | 0.12% |
| Action | Overall (%) |
|---|---|
| BUY | 17% |
| NEUTRAL / HOLD | 13% |
| SELL | 70% |
Most popular Questions & Answers about ASTRAZEN (/ FAQ ASTRAZEN)
AstraZenca Pharma India Ltd. stock last traded price is 6695.50. ASTRAZEN share price moved Down by -1.02% from its previous close of Rs 6764.5.
AstraZenca Pharma India Ltd. share price trend is Down with a total of 14843 stocks traded till now. It has touched an intraday high of Rs 9947.995 and an intraday low of Rs 6600. The ASTRAZEN trading at 6695.50, Down by Rs. -69.00, or -1.02 percent which suggests that most of the Traders are anticipating that the price of ASTRAZEN share should go Down and the Stop Loss will be around 6689.25.
The market cap of AstraZenca Pharma India Ltd. is ₹7044.8 (in Cr) as of Sep 14, 2026.
The current price to earning ratio for AstraZenca Pharma India Ltd. as of Sep 14, 2026 is 98.68.
The current price to book ratio for AstraZenca Pharma India Ltd. as of Sep 14, 2026 is 18.38.
The highest price of AstraZenca Pharma India Ltd. stock is ₹9849.5 in the last 52-week.
The lowest price of AstraZenca Pharma India Ltd. stock is ₹6600 in the last 52-week.
AstraZenca Pharma India Ltd. share trading at ₹6695.50, Down by Rs. -69.00, or -1.02 percent which suggests that most of the traders are anticipating that the price of ASTRAZEN share should go Down.
In 2026, Stock price target for AstraZenca Pharma India Ltd. (ASTRAZEN) will be around ₹6919.5 on downside and ₹8727.2 on upside. AstraZenca Pharma India Ltd. share price target is based on current financial year earings of the company.
In 2027, Stock price target for AstraZenca Pharma India Ltd. (ASTRAZEN) will be around ₹8727.2 on downside and ₹10544.9 on upside. AstraZenca Pharma India Ltd. share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for AstraZenca Pharma India Ltd. (ASTRAZEN) will be around ₹10544.9 on downside and ₹11283 on upside. AstraZenca Pharma India Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for AstraZenca Pharma India Ltd. (ASTRAZEN) will be around ₹12186 AstraZenca Pharma India Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of ASTRAZEN.
The price of AstraZenca Pharma India Ltd. (ASTRAZEN) shares moved by -1.02%. The short-term trend for ASTRAZEN share price is Down. It implies that the share price of ASTRAZEN will stay the same tomorrow and that intraday traders should treat VWAP at 6689.25 as a stop loss. Investors with a long-term outlook can track ASTRAZEN long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of ASTRAZEN stock is 1036.4. Compared to the current market price of 6695.50 INR, the ASTRAZEN stock is Overvalued by 84.5%.
As per the fundamental analysis of AstraZenca Pharma India Ltd. (ASTRAZEN), it is of Economical quality in terms of earnings and profit margins with an EPS of 86.44. AstraZenca Pharma India Ltd. book value per share as of today is 364.29. The current price to book ratio for ASTRAZEN as of Sep 15, 2026 is 18.38.
NSE:ASTRAZEN News & Other Useful Information about ASTRAZEN Share Price
Peer Comparison of NSE: ASTRAZEN
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1835.00 | 16.35 | 97.89 |
| DIVISLAB | 9198.00 | 115.55 | 663.06 |
| MEDICAMEQ | 318.20 | 12.15 | 208.08 |
| CIPLA | 1351.00 | 51.67 | 434.03 |
| DRREDDY | 1145.00 | 53.19 | 380.63 |
| TORNTPHARM | 4850.00 | 87.32 | 235.7 |
| BIOCON | 382.00 | 1.27 | 166.51 |
| LUPIN | 2063.20 | 154.86 | 718.37 |
| ALKEM | 5161.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1660.00 | 46.49 | 403.84 |
| ABBOTINDIA | 26125.00 | 766.11 | 2448.41 |
| GLAXO | 2818.90 | 63.65 | 147.25 |
| IPCALAB | 1932.40 | 56.72 | 329.23 |
| LAURUSLABS | 1926.90 | 20.74 | 102.57 |
| LALPATHLAB | 1906.40 | 39.68 | 157.23 |
| PFIZER | 4041.60 | 170.54 | 963.41 |
| AJANTPHARM | 3510.40 | 89.3 | 363.23 |
| SANOFI | 3131.00 | 158.05 | 332.96 |
| NATCOPHARM | 819.15 | 82.14 | 481.67 |
| APLLTD | 824.75 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2371.70 | 1.24 | 881.78 |
| AAREYDRUGS | 98.50 | 2.39 | 53.38 |
| JUBLPHARMA | 1011.95 | 4.35 | 145.63 |
| SPARC | 188.00 | 48.14 | 40.45 |
| GRANULES | 872.60 | 23.25 | 180.42 |
| ASTRAZEN | 6695.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2570.60 | 55.52 | 285.6 |
| FDC | 349.70 | 21.19 | 161.21 |
| HIKAL | 212.22 | 9.34 | 96.63 |